Business classification

VCID: 10440740
    Profile

    Corporate information

    Official name
    SV Health Investors LLP

    Registration country
    Investment activity status
    Active investor

    Funds managed

    Fund Type Vintage
    SV Fund VI Venture

    Selected investments

    Country Notes
    Versicor
    N/A
    Initial investment. Round participant. Exited
    Strides Arcolab
    N/A
    Initial investment. Round participant. Exited
    Sadra Medical Inc
    United States N/A
    Initial investment. Round participant. Exited
    Physicians Dialysis Inc
    United States N/A
    Initial investment. Round participant. Exited
    OMS Foundations
    N/A
    Initial investment. Round participant. Exited
    Mindframe Inc
    United States N/A
    Initial investment. Round participant. Exited
    Leukosite Inc
    Developer of small molecule and monoclonal antibody therapeutics for inflammatory, autoimmune, and viral diseases, as well as for cancer applications.
    United States N/A
    Initial investment. Round participant. Exited
    Insulet Corp
    United States N/A
    Initial investment. Round participant. Exited
    GlycoFi Inc
    N/A
    Initial investment. Round participant. Exited
    ESBATech AG
    Switzerland based Biomedical Research Unit of Alcon
    Switzerland N/A
    Initial investment. Round participant. Exited
    Coral Therapeutics
    N/A
    Initial investment. Round participant. Exited
    ValenTx Inc
    Developer of a new therapy to treat patients with obesity and obesity-related metabolic disorders such as type-2 diabetes and hypertension.
    United States N/A
    Initial investment. Round participant. Exited
    Stimwave Technologies Inc
    Provider of wireless microsize injectable medical devices for neurology markets.
    United States N/A
    Initial investment. Round participant. Exited
    Rinat Neuroscience Corp
    Discovers and commercializes novel antibody based drugs and drug targets for the major mental and neuro-degenerative diseases
    United States N/A
    Initial investment. Round participant. Exited
    Phase Forward Inc
    United States N/A
    Initial investment. Round participant. Exited
    Ocular Therapeutix Inc
    A medical device company that is currently engaged in the development of in situ formed hydrogel therapeutic products specifically for ophthalmology.
    United States N/A
    Initial investment. Round participant. Exited
    Micromet Inc
    Designs and develops innovative antibody based drugs for the treatment of cancer, autoimmune and inflammatory diseases
    United States N/A
    Initial investment. Round participant. Exited
    LensX Lasers Inc
    United States N/A
    Initial investment. Round participant. Exited
    Incyte Pharmaceuticals
    N/A
    Initial investment. Round participant. Exited
    Genosis PLC
    Delivering innovative and unique solutions to consumer issues arising in the field of reproductive health
    United Kingdom N/A
    Initial investment. Round participant. Exited